718 related articles for article (PubMed ID: 23291100)
1. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.
Lowes MA; Russell CB; Martin DA; Towne JE; Krueger JG
Trends Immunol; 2013 Apr; 34(4):174-81. PubMed ID: 23291100
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation through the IL-23/T17 Axis in a MALT1-Dependent Manner.
Zhang S; Wang M; Wang C; Wang G; Sun K; Xiong S; Cheng L; Yang D; Lin X; Zhao X
J Immunol; 2021 Feb; 206(4):839-848. PubMed ID: 33419765
[TBL] [Abstract][Full Text] [Related]
3. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Jordan CT; Cao L; Roberson ED; Duan S; Helms CA; Nair RP; Duffin KC; Stuart PE; Goldgar D; Hayashi G; Olfson EH; Feng BJ; Pullinger CR; Kane JP; Wise CA; Goldbach-Mansky R; Lowes MA; Peddle L; Chandran V; Liao W; Rahman P; Krueger GG; Gladman D; Elder JT; Menter A; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):796-808. PubMed ID: 22521419
[TBL] [Abstract][Full Text] [Related]
4. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
Mellett M; Meier B; Mohanan D; Schairer R; Cheng P; Satoh TK; Kiefer B; Ospelt C; Nobbe S; Thome M; Contassot E; French LE
J Invest Dermatol; 2018 Sep; 138(9):2010-2023. PubMed ID: 29689250
[TBL] [Abstract][Full Text] [Related]
5. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
7. PSORS2 is due to mutations in CARD14.
Jordan CT; Cao L; Roberson ED; Pierson KC; Yang CF; Joyce CE; Ryan C; Duan S; Helms CA; Liu Y; Chen Y; McBride AA; Hwu WL; Wu JY; Chen YT; Menter A; Goldbach-Mansky R; Lowes MA; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):784-95. PubMed ID: 22521418
[TBL] [Abstract][Full Text] [Related]
8. Psoriasis Plays a Wild CARD.
Van Nuffel E; Afonina IS; Beyaert R
J Invest Dermatol; 2018 Sep; 138(9):1903-1905. PubMed ID: 30143077
[TBL] [Abstract][Full Text] [Related]
9. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
Katayama H
Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Genetic Heterogeneity of
Israel L; Mellett M
Front Immunol; 2018; 9():2239. PubMed ID: 30386326
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.
Signa S; Campione E; Rusmini M; Chiesa S; Grossi A; Omenetti A; Caorsi R; Viglizzo GM; Galluzzo M; Bianchi L; Talamonti M; Orlandi A; Martini A; Ceccherini I; Gattorno M
Pediatr Rheumatol Online J; 2019 Jul; 17(1):38. PubMed ID: 31286971
[TBL] [Abstract][Full Text] [Related]
12. Targeting interleukin-22 in psoriasis.
Hao JQ
Inflammation; 2014 Feb; 37(1):94-9. PubMed ID: 23978911
[TBL] [Abstract][Full Text] [Related]
13. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Lovato P; Norsgaard H; Tokura Y; Røpke MA
J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
[TBL] [Abstract][Full Text] [Related]
14. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines.
Fitch E; Harper E; Skorcheva I; Kurtz SE; Blauvelt A
Curr Rheumatol Rep; 2007 Dec; 9(6):461-7. PubMed ID: 18177599
[TBL] [Abstract][Full Text] [Related]
16. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
17. Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation.
Takeichi T; Kobayashi A; Ogawa E; Okuno Y; Kataoka S; Kono M; Sugiura K; Okuyama R; Akiyama M
Br J Dermatol; 2017 Oct; 177(4):e133-e135. PubMed ID: 28295164
[No Abstract] [Full Text] [Related]
18. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.
Carrier Y; Ma HL; Ramon HE; Napierata L; Small C; O'Toole M; Young DA; Fouser LA; Nickerson-Nutter C; Collins M; Dunussi-Joannopoulos K; Medley QG
J Invest Dermatol; 2011 Dec; 131(12):2428-37. PubMed ID: 21881584
[TBL] [Abstract][Full Text] [Related]
19. Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki DM; Liu L; Choon SE; David Burden A; Griffiths CEM; Navarini AA; Tan ES; Irvine AD; Ranki A; Ogo T; Petrof G; Mahil SK; Duckworth M; Allen MH; Vito P; Trembath RC; McGrath J; Smith CH; Capon F; Barker JN
J Invest Dermatol; 2015 Dec; 135(12):2964-2970. PubMed ID: 26203641
[TBL] [Abstract][Full Text] [Related]
20. The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
Afonina IS; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Staal J; Beyaert R
EMBO Rep; 2016 Jun; 17(6):914-27. PubMed ID: 27113748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
